Storia della carriera di Greg F. Walker
Precedenti posizioni note di Greg F. Walker
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| Ludwig-Maximilians-Universität München | Corporate Officer/Principal | 01/01/2006 | 01/01/2006 |
| University of Vienna | Corporate Officer/Principal | 01/01/2000 | 01/01/2002 |
Haemostatix Ltd.
 Haemostatix Ltd. Pharmaceuticals: MajorHealth Technology Haemostatix Ltd. designs and develops solutions for haemostasis and thrombosis. Its products include Rapid and effective haemostatic action which is new class of topical coagulant or haemostat that is applied directly to a wound during surgery to control bleeding, and ready-to-use formulations, blood-free ingredients and a new class with a unique mode of action. The company was founded by Sarah Middleton and Alison Goodall in 2003 and is headquartered in Nottingham, the United Kingdom. | Corporate Officer/Principal | - | - |
Formazione di Greg F. Walker
| University of Otago | Doctorate Degree |
Statistiche
Distribuzione geografica
| Regno Unito | 2 |
| Nuova-Zelanda | 2 |
| Austria | 2 |
Posizioni
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 1 |
Settori
| Consumer Services | 4 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
Haemostatix Ltd.
Haemostatix Ltd. Pharmaceuticals: MajorHealth Technology Haemostatix Ltd. designs and develops solutions for haemostasis and thrombosis. Its products include Rapid and effective haemostatic action which is new class of topical coagulant or haemostat that is applied directly to a wound during surgery to control bleeding, and ready-to-use formulations, blood-free ingredients and a new class with a unique mode of action. The company was founded by Sarah Middleton and Alison Goodall in 2003 and is headquartered in Nottingham, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Greg F. Walker
- Esperienza
